Epioxa is the only FDA-approved, non- invasive, epithelium-on, oxygen-enriched, corneal cross-linking treatment for keratoconus (KC).
Take care of your KC: Early treatment is key to help halt the progression of KC and prevent further vision loss.
Epioxa treatment is a procedure performed by your doctor 1 eye at a time.
Epioxa treatment is non-invasive because it does not remove the outer layer of the cornea, called the Epioxa treatment works using 3 parts.
Epioxa is the only FDA-approved, epithelium-on, corneal cross-linking treatment for keratoconus (KC)
Yes, the safety and efficacy of Epioxa were studied in 2 prospective, multicenter, randomized 2:1 procedure/placebo-controlled clinical trials, and was approved by the FDA for the treatment of keratoconus in adults and pediatric patients aged 13 years and older. For complete information, please see full Prescribing Information.
